The longer we have hepatitis B, the higher our risk of developing liver cancer. With every decade of life, our liver cancer risk increases 2.7-times, according to a report on Viral Hepatitis in the Elderly published in the American Journal of Gastroenterology.
But current medical guidelines don’t spell out exactly when liver cancer testing should begin in many hepatitis B patients who don’t have liver damage (cirrhosis) or a family history of liver cancer, and are not of Asian or African descent.
Age is clearly an important factor when it comes to liver cancer, “… but current guidelines only provide age-specific recommendations for (liver cancer) surveillance in hepatitis B carriers of Asian ethnicity (men over age 40 and women over age 50),” a team of University of Miami and Veterans Affairs researchers wrote in the journal article. Continue reading "Your Doctor Not Screening You for Liver Cancer? Time for a Talk"→
October is Liver Cancer Awareness Month. It may be a sleeper of a event when compared to other health campaigns, but for us who live with viral hepatitis, it’s an uncomfortable but critical reminder of the importance of monitoring our liver health to prevent cancer.
Viral hepatitis, especially B and C, are viral infections that can cause liver cancer (also called hepatocellular carcinoma or HCC.) Researchers are still studying why some people are more prone to liver cancer, but we who live with chronic hepatitis B or C have a 25 to 40 percent lifetime risk of developing liver cancer. The infection, which hijacks our liver cells to manufacture more virus, causes inflammation, scarring and even cancer as the liver cells grow out of control.
HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:
HBV Liver Cancer Requires Aggressive Treatment from the Start
Experts: Treat Cirrhotic Patients, Even if Viral Load Is Low
Some Patients Can Safely Stop Antiviral After Four Years
Tenofovir Safe and Effective in Pregnant Women with Drug Resistance
Researchers Discover Why Children Become Chronically Infected
Expert Recommends Treatment for Mental Confusion from Cirrhosis
Antivirals Increase Survival After Liver Cancer Treatment
HBV Patients with Diabetes Have a Higher Risk of Liver Cancer
Long-term Antiviral Use Increases Hip Fracture Rates Slightly
Second Vaccine Series May Be Needed for Children with Celiac Disease
Researchers Find HBV B Strain in Cuba Did Not Come from Africa
What support services are available for patients and families that are facing liver cancer? Are there any assistance programs to help pay for treatment or other costs? What about online or community support?
Listen to this webinar from the Hepatitis B Foundation’s Liver Cancer Connect program. Guest speakers Karla Pillote, a nurse practitioner at Johns Hopkins’ Sibley Memorial Hospital in Washington DC, and Andrea Wilson, founder of BlueFaery: The Adrienne Wilson Liver Cancer Association, explain how families can access valuable services.
In celebration of Asian Pacific Heritage Month, Dr. moon Chen, Principal Investigator for the Asian American Network for Cancer Awareness Research and Training (AANCART) and UC Davis professor, reflects on the unnecessary cancer burden in Asian American and Pacific Islanders, including the burden of hepatitis B related liver cancer. Continue reading "May is Asian Pacific American Heritage Month"→